_id
690f355accc777a4e85d16d8
Capt
Ticker
BIOA
Name
BioAge Labs, Inc
Exchange
NASDAQ
Address
1445A South 50th Street, Richmond, CA, United States, 94804
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://bioagelabs.com
Description
BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. It also provides azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.
Last Close
19.38
Volume
311573
Current Price
20.535
Change
0.375
Last Updated
2026-01-20T16:34:25.359Z
Image
data:image/webp;base64,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
Ipo Date
2024-09-26T00:00:00.000Z
Market Cap
722837504
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.4406666666666667
Sentiment Sources
3
Rating
2.5
Target Price
12
Strong Buy
0
Buy
0
Hold
3
Sell
0
Strong Sell
1
Current Quarter
2025-09-30
Revenue
2054000
Cost Of Revenue
-
Gross Profit
2054000
Operating Expenses
25194000
Operating Income
-23140000
Interest Expense
149000
Pretax Income
-20171000
Net Income
-20171000
Eps
-0.5626493495669196
Dividends Per Share
-
Shares Outstanding
35855037
Income Tax Expense
-
EBITDA
-19973000
Operating Margin
-1126.5822784810125
Total Other Income Expense Net
2969000
Cash
215573000
Short Term Investments
70205000
Receivables
515000
Inventories
-
Total Current Assets
290828000
Property Plant Equipment
3857000
Total Assets
305090000
Payables
5018000
Short Term Debt
4706000
Long Term Debt
-
Total Liabilities
27626000
Equity
277464000
Bs_currency_symbol
USD
Depreciation
49000
Change In Working Capital
1227000
Cash From Operations
-16044000
Capital Expenditures
22000
Cash From Investing
12841000
Cash From Financing
-1544000
Net Change In Cash
-4757000
Cf_currency_symbol
USD
PE
1.4813
PB
2.653246943008823
ROE
-7.269771934377073
ROA
-6.6114916909764325
FCF
-16066000
Fcf Percent
-7.821811100292113
Piotroski FScore
1
Health Score
35
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
3
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
2054000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
2054000
Quarters > 0 > income Statement > operating Expenses
25194000
Quarters > 0 > income Statement > operating Income
-23140000
Quarters > 0 > income Statement > interest Expense
149000
Quarters > 0 > income Statement > pretax Income
-20171000
Quarters > 0 > income Statement > net Income
-20171000
Quarters > 0 > income Statement > eps
-0.5626493495669196
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
35850037
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-19973000
Quarters > 0 > income Statement > operating Margin
-1126.5822784810125
Quarters > 0 > income Statement > total Other Income Expense Net
2969000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
215573000
Quarters > 0 > balance Sheet > short Term Investments
70205000
Quarters > 0 > balance Sheet > receivables
515000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
290828000
Quarters > 0 > balance Sheet > property Plant Equipment
3857000
Quarters > 0 > balance Sheet > total Assets
305090000
Quarters > 0 > balance Sheet > payables
5018000
Quarters > 0 > balance Sheet > short Term Debt
4706000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
27626000
Quarters > 0 > balance Sheet > equity
277464000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-20171000
Quarters > 0 > cash Flow > depreciation
49000
Quarters > 0 > cash Flow > change In Working Capital
1227000
Quarters > 0 > cash Flow > cash From Operations
-16044000
Quarters > 0 > cash Flow > capital Expenditures
22000
Quarters > 0 > cash Flow > cash From Investing
12841000
Quarters > 0 > cash Flow > cash From Financing
-1544000
Quarters > 0 > cash Flow > net Change In Cash
-4757000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.5626493495669196
Quarters > 0 > ratios > PB
2.653246943008823
Quarters > 0 > ratios > ROE
-7.269771934377073
Quarters > 0 > ratios > ROA
-6.6114916909764325
Quarters > 0 > ratios > FCF
-16066000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-7.821811100292113
Quarters > 0 > health Score
35
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
2412000
Quarters > 1 > income Statement > cost Of Revenue
58000
Quarters > 1 > income Statement > gross Profit
2412000
Quarters > 1 > income Statement > operating Expenses
27183000
Quarters > 1 > income Statement > operating Income
-24771000
Quarters > 1 > income Statement > interest Expense
201000
Quarters > 1 > income Statement > pretax Income
-21563000
Quarters > 1 > income Statement > net Income
-21563000
Quarters > 1 > income Statement > eps
-0.6014777613758111
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
35850037
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-21304000
Quarters > 1 > income Statement > operating Margin
-1026.9900497512438
Quarters > 1 > income Statement > total Other Income Expense Net
3208000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
220330000
Quarters > 1 > balance Sheet > short Term Investments
76965000
Quarters > 1 > balance Sheet > receivables
603000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
301697000
Quarters > 1 > balance Sheet > property Plant Equipment
4006000
Quarters > 1 > balance Sheet > total Assets
322148000
Quarters > 1 > balance Sheet > payables
1329000
Quarters > 1 > balance Sheet > short Term Debt
6226000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
27367000
Quarters > 1 > balance Sheet > equity
294781000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-21563000
Quarters > 1 > cash Flow > depreciation
58000
Quarters > 1 > cash Flow > change In Working Capital
-1787000
Quarters > 1 > cash Flow > cash From Operations
-19969000
Quarters > 1 > cash Flow > capital Expenditures
159000
Quarters > 1 > cash Flow > cash From Investing
-15641000
Quarters > 1 > cash Flow > cash From Financing
-1500000
Quarters > 1 > cash Flow > net Change In Cash
-37156000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.6014777613758111
Quarters > 1 > ratios > PB
2.4973811398801145
Quarters > 1 > ratios > ROE
-7.314921925090152
Quarters > 1 > ratios > ROA
-6.693507332033724
Quarters > 1 > ratios > FCF
-20128000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-8.344941956882256
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1451000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
1451000
Quarters > 2 > income Statement > operating Expenses
17897000
Quarters > 2 > income Statement > operating Income
-16446000
Quarters > 2 > income Statement > interest Expense
255000
Quarters > 2 > income Statement > pretax Income
-12928000
Quarters > 2 > income Statement > net Income
-12928000
Quarters > 2 > income Statement > eps
-0.3606132958802804
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
35850037
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-12636000
Quarters > 2 > income Statement > operating Margin
-1133.4252239834595
Quarters > 2 > income Statement > total Other Income Expense Net
3518000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
257486000
Quarters > 2 > balance Sheet > short Term Investments
63032000
Quarters > 2 > balance Sheet > receivables
361000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
324813000
Quarters > 2 > balance Sheet > property Plant Equipment
4130000
Quarters > 2 > balance Sheet > total Assets
343841000
Quarters > 2 > balance Sheet > payables
3989000
Quarters > 2 > balance Sheet > short Term Debt
6700000
Quarters > 2 > balance Sheet > long Term Debt
1056000
Quarters > 2 > balance Sheet > total Liabilities
30674000
Quarters > 2 > balance Sheet > equity
313167000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-12928000
Quarters > 2 > cash Flow > depreciation
37000
Quarters > 2 > cash Flow > change In Working Capital
-7532000
Quarters > 2 > cash Flow > cash From Operations
-17363000
Quarters > 2 > cash Flow > capital Expenditures
426000
Quarters > 2 > cash Flow > cash From Investing
-77988000
Quarters > 2 > cash Flow > cash From Financing
-1500000
Quarters > 2 > cash Flow > net Change In Cash
-96863000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.3606132958802804
Quarters > 2 > ratios > PB
2.3507601688396287
Quarters > 2 > ratios > ROE
-4.128148879032593
Quarters > 2 > ratios > ROA
-3.759877385186758
Quarters > 2 > ratios > FCF
-17789000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-12.259820813232254
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
25362000
Quarters > 3 > income Statement > operating Income
-25362000
Quarters > 3 > income Statement > interest Expense
319000
Quarters > 3 > income Statement > pretax Income
-21129000
Quarters > 3 > income Statement > net Income
-21129000
Quarters > 3 > income Statement > eps
-0.5893717766595331
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
35850037
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-20763000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
4233000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
354349000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
357103000
Quarters > 3 > balance Sheet > property Plant Equipment
791000
Quarters > 3 > balance Sheet > total Assets
358234000
Quarters > 3 > balance Sheet > payables
1996000
Quarters > 3 > balance Sheet > short Term Debt
6202000
Quarters > 3 > balance Sheet > long Term Debt
2502000
Quarters > 3 > balance Sheet > total Liabilities
35107000
Quarters > 3 > balance Sheet > equity
323127000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-21129000
Quarters > 3 > cash Flow > depreciation
47000
Quarters > 3 > cash Flow > change In Working Capital
13582000
Quarters > 3 > cash Flow > cash From Operations
-5138000
Quarters > 3 > cash Flow > capital Expenditures
26000
Quarters > 3 > cash Flow > cash From Investing
-26000
Quarters > 3 > cash Flow > cash From Financing
24902000
Quarters > 3 > cash Flow > net Change In Cash
19875000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.5893717766595331
Quarters > 3 > ratios > PB
2.2783008222618353
Quarters > 3 > ratios > ROE
-6.538915039597434
Quarters > 3 > ratios > ROA
-5.898100124499629
Quarters > 3 > ratios > FCF
-5164000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
43
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
78194000
Annuals > 0 > income Statement > operating Income
-78194000
Annuals > 0 > income Statement > interest Expense
2367000
Annuals > 0 > income Statement > pretax Income
-71109000
Annuals > 0 > income Statement > net Income
-71109000
Annuals > 0 > income Statement > eps
-6.6289736179733385
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
10727000
Annuals > 0 > income Statement > income Tax Expense
-71109000
Annuals > 0 > income Statement > EBITDA
-68575000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
7085000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
354349000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
357103000
Annuals > 0 > balance Sheet > property Plant Equipment
791000
Annuals > 0 > balance Sheet > total Assets
358234000
Annuals > 0 > balance Sheet > payables
1996000
Annuals > 0 > balance Sheet > short Term Debt
6202000
Annuals > 0 > balance Sheet > long Term Debt
2502000
Annuals > 0 > balance Sheet > total Liabilities
35107000
Annuals > 0 > balance Sheet > equity
323127000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-71109000
Annuals > 0 > cash Flow > depreciation
167000
Annuals > 0 > cash Flow > change In Working Capital
11176000
Annuals > 0 > cash Flow > cash From Operations
-51522000
Annuals > 0 > cash Flow > capital Expenditures
366000
Annuals > 0 > cash Flow > cash From Investing
-366000
Annuals > 0 > cash Flow > cash From Financing
381199000
Annuals > 0 > cash Flow > net Change In Cash
329392000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-6.6289736179733385
Annuals > 0 > ratios > PB
0.6817101170747106
Annuals > 0 > ratios > ROE
-22.006517561206586
Annuals > 0 > ratios > ROA
-19.849874662929818
Annuals > 0 > ratios > FCF
-51888000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
48400000
Annuals > 1 > income Statement > operating Income
-48400000
Annuals > 1 > income Statement > interest Expense
7794000
Annuals > 1 > income Statement > pretax Income
-63854000
Annuals > 1 > income Statement > net Income
-63854000
Annuals > 1 > income Statement > eps
-8.553775160053412
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
7465008
Annuals > 1 > income Statement > income Tax Expense
7794000
Annuals > 1 > income Statement > EBITDA
-55898000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-15454000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
21644000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
25306000
Annuals > 1 > balance Sheet > property Plant Equipment
518000
Annuals > 1 > balance Sheet > total Assets
25924000
Annuals > 1 > balance Sheet > payables
1866000
Annuals > 1 > balance Sheet > short Term Debt
45051000
Annuals > 1 > balance Sheet > long Term Debt
8201000
Annuals > 1 > balance Sheet > total Liabilities
199320000
Annuals > 1 > balance Sheet > equity
-173396000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-63854000
Annuals > 1 > cash Flow > depreciation
162000
Annuals > 1 > cash Flow > change In Working Capital
6710000
Annuals > 1 > cash Flow > cash From Operations
-37362000
Annuals > 1 > cash Flow > capital Expenditures
166000
Annuals > 1 > cash Flow > cash From Investing
-266000
Annuals > 1 > cash Flow > cash From Financing
34941000
Annuals > 1 > cash Flow > net Change In Cash
-2687000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-8.553775160053412
Annuals > 1 > ratios > PB
-0.884068486470276
Annuals > 1 > ratios > ROE
36.82553230755035
Annuals > 1 > ratios > ROA
-246.31229748495605
Annuals > 1 > ratios > FCF
-37528000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
39969000
Annuals > 2 > income Statement > operating Income
-39969000
Annuals > 2 > income Statement > interest Expense
241000
Annuals > 2 > income Statement > pretax Income
-39722000
Annuals > 2 > income Statement > net Income
-39722000
Annuals > 2 > income Statement > eps
-5.324377248789375
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
7460403
Annuals > 2 > income Statement > income Tax Expense
241000
Annuals > 2 > income Statement > EBITDA
-39352000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
247000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
27644000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
28030000
Annuals > 2 > balance Sheet > property Plant Equipment
374000
Annuals > 2 > balance Sheet > total Assets
28429000
Annuals > 2 > balance Sheet > payables
2261000
Annuals > 2 > balance Sheet > short Term Debt
216000
Annuals > 2 > balance Sheet > long Term Debt
2252000
Annuals > 2 > balance Sheet > total Liabilities
140988000
Annuals > 2 > balance Sheet > equity
-112559000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-39722000
Annuals > 2 > cash Flow > depreciation
129000
Annuals > 2 > cash Flow > change In Working Capital
795000
Annuals > 2 > cash Flow > cash From Operations
-36181000
Annuals > 2 > cash Flow > capital Expenditures
103000
Annuals > 2 > cash Flow > cash From Investing
-103000
Annuals > 2 > cash Flow > cash From Financing
2499000
Annuals > 2 > cash Flow > net Change In Cash
-33539000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-5.324377248789375
Annuals > 2 > ratios > PB
-1.3610584280688351
Annuals > 2 > ratios > ROE
35.28993683312752
Annuals > 2 > ratios > ROA
-139.7235217559534
Annuals > 2 > ratios > FCF
-36284000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2017-12-31
Annuals > 3 > income Statement > revenue
14942960
Annuals > 3 > income Statement > cost Of Revenue
22323456
Annuals > 3 > income Statement > gross Profit
-7380496
Annuals > 3 > income Statement > operating Expenses
102632808
Annuals > 3 > income Statement > operating Income
-110013304
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-102105041
Annuals > 3 > income Statement > net Income
-98151473
Annuals > 3 > income Statement > eps
-2.339835100718675
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
41948030
Annuals > 3 > income Statement > income Tax Expense
81735
Annuals > 3 > income Statement > EBITDA
-88723610
Annuals > 3 > income Statement > operating Margin
-736.2216321264328
Annuals > 3 > income Statement > total Other Income Expense Net
7908263
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
4631670
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
4864705
Annuals > 3 > balance Sheet > inventories
4823346
Annuals > 3 > balance Sheet > total Current Assets
15247873
Annuals > 3 > balance Sheet > property Plant Equipment
49461250
Annuals > 3 > balance Sheet > total Assets
69513895
Annuals > 3 > balance Sheet > payables
6153416
Annuals > 3 > balance Sheet > short Term Debt
4920221
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
47661200
Annuals > 3 > balance Sheet > equity
21852695
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-98151473
Annuals > 3 > cash Flow > depreciation
9346128
Annuals > 3 > cash Flow > change In Working Capital
17835729
Annuals > 3 > cash Flow > cash From Operations
-29789075
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
18847928
Annuals > 3 > cash Flow > net Change In Cash
-11528347
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-2.339835100718675
Annuals > 3 > ratios > PB
39.41860699790118
Annuals > 3 > ratios > ROE
-449.15042744155807
Annuals > 3 > ratios > ROA
-141.19691178288886
Annuals > 3 > ratios > FCF
-29789075
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1.99351902166639
Annuals > 3 > health Score
12
Valuation > metrics > PE
1.4813
Valuation > metrics > PB
2.653246943008823
Valuation > final Score
100
Valuation > verdict
42.6% Undervalued
Profitability > metrics > ROE
-7.269771934377073
Profitability > metrics > ROA
-6.9357145804392974
Profitability > metrics > Net Margin
-9.82035053554041
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.09956606983248277
Risk > metrics > Interest Coverage
-155.3020134228188
Risk > final Score
-561
Risk > verdict
High
Liquidity > metrics > Current Ratio
29.908268202385848
Liquidity > metrics > Quick Ratio
29.908268202385848
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
15
Prev Risks > 0
-433
Prev Risks > 1
-198
Prev Risks > 2
-258
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:29:19.140Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-19
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.56
Earnings History > 1 > eps Estimate
-0.5137
Earnings History > 1 > eps Difference
-0.0463
Earnings History > 1 > surprise Percent
-9.013
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-06
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.6
Earnings History > 2 > eps Estimate
-0.3814
Earnings History > 2 > eps Difference
-0.2186
Earnings History > 2 > surprise Percent
-57.3152
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.36
Earnings History > 3 > eps Estimate
-0.5276
Earnings History > 3 > eps Difference
0.1676
Earnings History > 3 > surprise Percent
31.7665
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-20
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-1
Earnings History > 4 > eps Estimate
-0.655
Earnings History > 4 > eps Difference
-0.345
Earnings History > 4 > surprise Percent
-52.6718
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-6.7
Earnings History > 5 > eps Estimate
-0.7343
Earnings History > 5 > eps Difference
-5.9657
Earnings History > 5 > surprise Percent
-812.4336
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-28
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.6
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.6
Earnings History > 6 > surprise Percent
-
BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. It also provides azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAnnovis Bio’s Stock Outlook Stabilizes Amid Key Regulatory and Clinical Developments - AD HOC NEWS
1/21/2026
Annovis Bio’s Stock Outlook Stabilizes Amid Key Regulatory and Clinical Developments AD HOC NEWS
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$12
Analyst Picks
Strong Buy
0
Buy
0
Hold
3
Sell
0
Strong Sell
1
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of BioAge Labs, Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0
Date
2025-09-30
EPS Actual
-0.56
EPS Estimate
-0.5137
EPS Difference
-0.0463
Surprise Percent
-9.013%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.